Trial
NCT03815942
VAccination in Early and ADvanced Prostate caNCEr
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Oxford
Collaborators
Barinthus Biotherapeutics
Condition
Intermediate Risk Prostate Cancer
Intervention
ChAdOx1-MVA 5T4 vaccine
Why stopped
COVID stopped all trials - and ADVANCE could not restart again after the pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-25